About this episode

Dr. Connie Lehman discusses her journey in creating Clairity, an AI platform for predicting breast cancer risk, and the challenges of integrating it into healthcare.

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman , founder and CEO of Clairity . Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram. A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imaging Specialist at Massachusetts General Brigham (on leave). She holds an MD and PhD from Yale and was named to Forbes' 50 Over 50 Innovators and TIME 100 World’s Most Influential Leaders in Health. In this interview, Connie discusses her experience translating academic research into a commercially viable startup, the massive undertaking of generating clinical evidence when you’re creating a new category, and how Clairity is approaching adoption on two fronts: fitting into physician workflows and building access pathways for patients. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. And if…

People in this episode

Host: Scott Nelson

Guest: Dr. Connie Lehman

Topics covered

• breast cancer
• AI in healthcare
• medical startups
• clinical evidence
• patient access
• physician workflows

Keywords

• breast cancer risk
• AI platform
• Clairity
• medical device
• clinical evidence
• healthcare innovation
• patient pathways

Mentioned in this episode

Organizations: Clairity, Harvard Medical School, Massachusetts General Brigham, Forbes, TIME

More episodes of Medsider: Learn from Medtech and Healthtech Founders and CEOs

• Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan · June 8, 2026 · 56 min
• Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh · June 1, 2026 · 51 min
• Translating Academic IP into a Medtech Startup: Interview with Echopoint Medical CEO Antony Odell · May 18, 2026 · 52 min
• Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus · May 11, 2026 · 55 min

Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.